These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5720700)

  • 21. [Clinical evaluation of a new factor VIII concentrate in hemophilic children].
    Carnelli V; Cultrera S; Simoni L; Pasqui G; Busso B; Bagnato L
    Pediatr Med Chir; 1983; 5(3):49-55. PubMed ID: 6417627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of haemophilic synovitis: prophylaxis.
    Lee CA
    Haemophilia; 2007 Nov; 13 Suppl 3():20-5. PubMed ID: 17822517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
    Nijdam A; Altisent C; Carcao MD; Cid AR; Claeyssens-Donadel S; Kurnik K; Ljung R; Nolan B; Petrini P; Platokouki H; Rafowicz A; Thomas AE; Fischer K;
    Haematologica; 2015 Mar; 100(3):e84-6. PubMed ID: 25527565
    [No Abstract]   [Full Text] [Related]  

  • 24. [A randomized in vivo trial of 3 factor VIII preparations].
    Jacobsen L; Clausen C; Jans H; Gormsen J
    Ugeskr Laeger; 1983 Mar; 145(10):739-42. PubMed ID: 6407165
    [No Abstract]   [Full Text] [Related]  

  • 25. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD; Pipe SW
    Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prophylactic therapy of patients with hemophilia A].
    Blombäck M
    Lakartidningen; 1968 Mar; 65(10):1029-30. PubMed ID: 5720699
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
    Björkman S; Folkesson A; Berntorp E
    Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation.
    Maher KN; Gibson E; Warren BB; Funk SM; Shearer R; Buckner TW; Wang M; Manco-Johnson MJ; Ng CJ
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28577. PubMed ID: 32881253
    [No Abstract]   [Full Text] [Related]  

  • 30. Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate.
    Mäkipernaa A; von Bonsdorff L
    Haemophilia; 2008 May; 14(3):612-4. PubMed ID: 18312362
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylaxis in haemophilic children.
    Liesner RJ
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S7-10. PubMed ID: 9351529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can hemophilic patients be adequately maintained with cryoprecipitates? Or is it desirable or even necessary to manufacture and administer highly concentrated AHF products?
    Vox Sang; 1972; 22(6):554-65. PubMed ID: 5050492
    [No Abstract]   [Full Text] [Related]  

  • 33. [A protocol for the orthopaedic prophylaxis in the rehabilitation of haemarthrosis in haemophilia A ].
    Aznar JA; Miranda L; Espinosa C; Querol F; Martín G; Marty ML
    Sangre (Barc); 1982; 27(2):156-64. PubMed ID: 6812226
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-lasting recombinant factor VIII proteins for hemophilia A.
    Shapiro AD
    Hematology Am Soc Hematol Educ Program; 2013; 2013():37-43. PubMed ID: 24319160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihaemophilic cryoprecipitate from fresh plasma and its use in haemophilia.
    Brüster H; Glassner K; Riech PC
    Ger Med Mon; 1968 Mar; 13(3):129-33. PubMed ID: 5656869
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method.
    Durisová M; Dedík L; Bátorová A; Sakalová A; Hedera J
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):217-26. PubMed ID: 9646284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Teeth extractions in 35 patients with hemophilia].
    Zhou SM; Gi LX; Yang TY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Sep; 29(5):291-3. PubMed ID: 7743865
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
    Berntorp E
    Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG].
    Foltyn H; Wróbel I
    Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.